BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Policy

  India’s Top COVID-19 Vaccine Makers Halt Production, “Dumb Luck” and a New Variant

  Two companies in India have halted vaccine manufacturing, which could be a sign that the pandemic may be coming to an end. For that and more COVID-19 news, continue reading.

  April 4, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  AbbVie, Sage and MT Pharma Anchor Weekend Highlights at AAN

  The 2022 American Academy of Neurology (AAN) Annual Meeting kicked off on Saturday and will continue on through Thursday.

  April 4, 2022

   · 

  4 min read

   · 

  Hayley Shasteen
• 

  Policy

  High Profile MIT Scientist Resigns in Wake of Sexual Harassment Allegations

  David Sabatini’s resignation follows a decision from three senior MIT officers that recommended his tenure’s revocation.

  April 4, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Adial is Leveraging Genomics to Treat “Pervasive” Alcohol Use Disorder

  Alcohol use disorder is common among the population for a very long time. Adial is planning to leverage genomics that can treat pervasive alcohol use disorder.

  April 4, 2022

   · 

  6 min read

   · 

  Abbey Glasure
• 

  Drug Development

  Lexicon, BridgeBio, Esperion, Pfizer, More Celebrate Wins at 71st ACC Meeting

  The 71st annual American College of Cardiology’s Scientific Session saw several wins over the weekend, led by some of the life sciences industries’ largest companies.

  April 4, 2022

   · 

  7 min read

   · 

  Vanessa Doctor, RN & Mark Terry
• 

  Policy

  Former Harvard Professor Forced to Retract Multiple Articles over Ethics Concerns

  A former Harvard University professor of ophthalmology has retracted eight research paper abstracts published in professional journals over ethics concerns.

  April 4, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  New Studies Support Benefit of Merck’s Molnupiravir

  Three studies supporting Merck and Ridgeback Biotherapeutics’ Lagevrio (molnupiravir) will be presented at the ECCMID 2022 in Lisbon from April 23-26.

  April 4, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Novartis Undertakes Transformational Makeover to Fortify International Position (UPDATED)

  As Novartis explores the possible sell-off of its Sandoz business, the company is undergoing a significant transformation that it says will save about $1 billion in operations costs by 2024.

  April 4, 2022

   · 

  4 min read

   · 

  Alex Keown
• 

  Business

  NCI Director Ned Sharpless is Latest Departure as NIH Changes Guard

  Norman E. “Ned” Sharpless will step down from his role as director of the National Cancer Institute (NCI) at the end of this month, after serving in the role since 2017.

  April 4, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Manufacturing Frustration Sets Alnylam Back 3 Months with Vutrisiran

  The delay is related to a third-party secondary packaging and labeling facility that Alnylam planned to use for the launch of vutrisiran.

  April 4, 2022

   · 

  3 min read

   · 

  Hayley Shasteen